Greater Manchester has one of the highest rates of cardiovascular disease and cardiovascular death in the UK (Figure 1)(10). CKD is one of the largest modifiable risk factors for cardiovascular disease.

Premature CVD death rate rises in line with deprivation.png

Whilst all patients with CKD should have their kidney failure risk assessed at least on an annual basis via a blood and urine test, GM CVD Prevent data suggests this only occurs in 18-30% of patients with "coded CKD". Evidence from GM show uptake of medications which mitigate against CKD decline is low- ACE inhibitors or ARBs were shown to reduce renal disease progression over 20 years ago. However, uptake is only 60-70% in GM.

The Northwest Kidney Network (NWKN) has a workstream dedicated to chronic kidney disease (CKD) in Greater Manchester. In March 2024 they applied for transformational funds from Specialised Commissioning North West with agreement from Greater Manchester Integrated care board (ICB) team to undertake a CKD pilot in the GM area. This project is called CKD DREAM.

CKD-DREAM project

D-Data driven approach to CKD.
R-Risk based protocolised Renal care.
E-Educationally aligned.
A-Approachable And collAborative renal support to primary care
M2-Medicines optimisation in Manchester

The aim of this pilot is to:

  • Identify patients at risk of CKD and assess their risk of progression.
  • Improve management of patients at high risk of progressive CKD.
  • Improve the knowledge, confidence and understanding of CKD across all healthcare systems and providers.
  • Demonstrate the benefit of closer collaborative and approachable nephrology support to primary care.

This pilot project is aligned to the recommendations of the NHS long term plan that spans prevention, diagnosis, and management of long-term conditions. It is also aligned to the National Renal Service Transformation Programmes recommendations for CKD and the Renal GIRFT recommendations. Our proposed strategy aligns with the objectives of the Core20PLUS5 initiative and seeks to enhance overall health outcomes and reduce health inequalities within the GM ICB. Healthcare does not solely comprise of healthcare professionals and patients. It is a complex interplay of society, economics, politics, and culture. Targets help drive performance and compare locality performances against each other. Local nephrologists building relationships with local healthcare professionals should enable better understanding of the complexities of local issues and ultimately help address the unmet healthcare needs for each locality. 

The project is focussed on delivering an accelerated risk-based approach to CKD care underpinned by 4 main aims: 

  • Identification of patients at risk of CKD in Oldham and Tameside and assess their risk of CKD progression.
  • Improve the management of patients in these localities at high risk of progressive CKD.
  • Improve the confidence and understanding of CKD across all healthcare systems within Oldham and Tameside so there is a sustainable improvement legacy to the project.
  • Demonstrate the benefit of closer collaborative and approachable nephrology support to primary care in these localities.

This project currently being undertaken in GM is in its very early stages, but we will keep you updated with progress at regular intervals.